Back to company

VIAD PHARMA ApS: Financial statements 2021

CVR: 36433892

VIAD PHARMA ApS (CVR 36433892) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 1,048,036 and a net result of DKK 250,426 compared with DKK 457,510 the year before. That is a decrease of 18.8% compared with the year before. Equity amounted to DKK 318,793. The solvency ratio was 16%.

Gross Profit
1,048,036 kr.
Profit/Loss
250,426 kr.
Equity
318,793 kr.
Total Assets
1,988,241 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021-1 mio.250 t.319 t.-
2020-1.3 mio.458 t.526 t.-
2019-1.4 mio.555 t.668 t.-
2018-1.4 mio.553 t.714 t.-
2017-1.5 mio.677 t.761 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like VIAD PHARMA ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2021

VIAD PHARMA ApS: The 2020 annual report is outMay 14, 2021

VIAD PHARMA ApS has published its annual report for 2020. Gross profit came to DKK 1,290,916, and the net result was DKK 457,510.

About VIAD PHARMA ApS

VIAD PHARMA ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2014. The company is registered under the industry Anden teknisk rådgivning. The management consists of Heidi Meier. The company is owned by HEIDI MEIER HOLDING ApS. The company has 1 employee. In 2025, the company reported a gross profit of DKK 1,031,002 and a net result of DKK 168,032 compared with DKK 808,813 the year before. Equity amounted to DKK 236,399.